Luma Health vs pVerify
Two Patient Access & Intake vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Luma Health | pVerify | |
|---|---|---|
| Pricing model | Subscription (per user or PMPM) · Custom quote, third parties estimate ~$250/user/month | Per-transaction / per-chart · Per-check API pricing, volume tiers |
| Speed to go live | EHR-integrated deployments run 60 to 120 days | API keys in days; portal is self-serve |
| Automation model | Software platform · Patient access automation with AI concierge | Software platform · API and portal, no services layer |
| Built for | Mid-size groups, Enterprise systems | Small practices, Mid-size groups, Billing companies |
| Security posture | SOC 2 Type II, HITRUST, ISO 27001, HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 11 yrs (est. 2015) | 20 yrs (est. 2006) |
| Financial backing | $160M · Series C | Acquired by DoseSpot (2023) |
| Named customers | 5 named | None public |
| Published results | No public numbers | No public numbers |
| Documented integrations | 5 listed | 4 listed |
| Third-party validation | None found | KLAS / analyst cited |
Bottom line
- Pick Luma if you're a mid-size or enterprise group that wants scheduling, reminders, and patient communication wired deeply into your EHR.
- Pick pVerify if you want to embed accurate, specialty-aware eligibility checks into your own software or intake workflow through an API rather than buy a full RCM platform.
Luma Health
Patient access, intake, and communication built on the EHR
- Founded
- 2015
- HQ
- San Francisco, CA
- Stage
- Series C
- Raised
- $160M
What it does
- Self-scheduling and automated waitlist backfill
- Appointment reminders and two-way patient messaging
- Digital intake, forms, and e-consents
- AI agents for inbound calls and faxes
- Multilingual outreach and patient feedback workflows
- Referral management and recall campaigns
Where it's strong
- Deep bidirectional EHR integration means schedules and intake data stay in the system of record instead of a side database.
- Large installed base (over 1,000 health systems and 100 million patients after the Tonic deal) gives buyers plenty of comparable references.
- The Tonic acquisition adds strong dynamic intake and patient-reported outcomes, especially for Oracle Health shops.
What buyers should weigh
- Epic customers should compare carefully against MyChart and Cheers features they already license before paying for overlap.
- The platform is modular, so quoted price varies a lot with module count; scope the contract tightly.
- Tonic integration is recent (late 2025), so ask how the combined product roadmap affects the modules you are buying.
Named customers
Cook County Health · Montefiore Health System · Banner Health · Kelsey-Seybold Clinic · Franciscan Health
Integrations
pVerify
REST APIs for real-time eligibility and benefits verification
- Founded
- 2006
- HQ
- Tustin, CA
- Stage
- Acquired by DoseSpot (2023)
- Raised
- n/a
What it does
- Real-time eligibility checks across 1,500+ payers
- Specialty-specific benefits parsing (vision, DME, therapy)
- Insurance discovery for unknown or inactive coverage
- Patient estimation and Medicare-specific checks (MBI lookup)
- Claim status and prior authorization support APIs
- Batch eligibility for appointment-day sweeps
Where it's strong
- Developer-first: well-documented APIs make it quick to embed eligibility into your own product.
- Specialty benefit parsing goes deeper than raw 270/271 responses from clearinghouses.
- Now part of PSG-backed DoseSpot, which adds financial stability and a bigger product family.
What buyers should weigh
- It solves front-end verification only; you still need separate tools for claims and denials.
- Named enterprise customer references are thin in public materials.
- Ongoing DoseSpot and Arrive Health consolidation (Interra Health) could shift roadmap priorities.
Integrations
Compare against the rest of Patient Access & Intake
Deciding between these two?
First Pass tracks Patient Access & Intake every week: funding, launches, and what changed since this page was written.